Abstract
Rationale: Chronic kidney disease (CKD) induces global and profound skeletal muscle mitochondrial alterations, which contribute to muscle mass loss and ultimately negatively affect patient outcome. Among derangements, changes in fission and fusion as well as in mitophagy are known to regulate mitochondrial function. n-3 polyunsaturated fatty acids (PUFA) reportedly improve mitochondrial function in several tissues and disease models, however their potential to modulate muscle mitochondrial dynamics, mitophagy and ultimately function in CKD is currently unknown.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.